Do you think that the more profit available to pharma, the more capable the workers attracted to the field will be? And therefore the faster results will be achieved? I don’t mean just the bench scientists, but all the other people - programmers, lawyers, managers, fabrication engineers, supply chain ops, etc - required to take an idea from paper to mass production. Having worked in biotech startups myself I understand how inefficient the current system is, but at the same time I can’t foresee a better one.